abstract |
OF THE INVENTION A compound having the general structure shown in Formula 1: R' R2 Ar2 5 Ar' O R3 (I) or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK1 receptors, for example 10 various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough. |